Editas Medicine (EDIT) Capital Expenditures (2015 - 2025)
Editas Medicine (EDIT) reported Capital Expenditures of -$114000.0 for Q3 2025, down 103.9% year-over-year from $2.9 million in Q3 2024, and down 200.0% on a QoQ basis from $114000.0 in Q1 2025.
Editas Medicine (EDIT) has 11 years of Capital Expenditures data on file, last reported at -$114000.0 in Q3 2025.
- Quarterly Capital Expenditures fell 103.9% year-over-year to -$114000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$8.2 million (down 243.75% YoY) and the FY2024 annual result came in at $65000.0, down 92.31% from the prior year.
- Capital Expenditures retreated to -$114000.0 in Q3 2025 per EDIT's latest filing, from $114000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $3.5 million in Q2 2024 and bottomed at -$8.2 million in Q4 2024.
- The 5-year median for Capital Expenditures is $388000.0 (2021), against an average of $320944.4.
- The widest annual swing landed in 2022, when Capital Expenditures soared 2576.19%; it then slumped 511.38% in 2023.
- Tracing EDIT's Capital Expenditures over 5 years: stood at $152000.0 in 2021, then jumped by 310.53% to $624000.0 in 2022, then tumbled by 511.38% to -$2.6 million in 2023, then plunged by 220.26% to -$8.2 million in 2024, then surged by 98.61% to -$114000.0 in 2025.
- Per Business Quant, the three latest EDIT Capital Expenditures figures stand at -$114000.0 (Q3 2025), $114000.0 (Q1 2025), and -$8.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -114,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | -8.22 Mn |
| Dec 31, 2024 | -8.22 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 624,000.00 |
| Dec 31, 2022 | 624,000.00 |
| Sep 30, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | -2.12 Mn |
| Jun 30, 2022 | -2.12 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 152,000.00 |
| Dec 31, 2021 | 152,000.00 |
| Sep 30, 2021 | -482,000.00 |
| Sep 30, 2021 | -482,000.00 |
| Jun 30, 2021 | 995,000.00 |
| Jun 30, 2021 | 995,000.00 |
| Mar 31, 2021 | 84,000.00 |
| Mar 31, 2021 | 84,000.00 |
| Dec 31, 2020 | -254,000.00 |
| Dec 31, 2020 | -254,000.00 |
| Sep 30, 2020 | -3.08 Mn |
| Sep 30, 2020 | -3.08 Mn |
| Jun 30, 2020 | 1.84 Mn |
| Jun 30, 2020 | 1.84 Mn |
| Mar 31, 2020 | 2.15 Mn |
| Mar 31, 2020 | 2.15 Mn |
| Dec 31, 2019 | -3.75 Mn |
| Dec 31, 2019 | -3.75 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | -260,000.00 |
| Jun 30, 2019 | -260,000.00 |
| Mar 31, 2019 | 356,000.00 |
| Mar 31, 2019 | 356,000.00 |
| Dec 31, 2018 | -2.68 Mn |
| Dec 31, 2018 | -2.68 Mn |
| Sep 30, 2018 | 2.97 Mn |
| Sep 30, 2018 | 2.97 Mn |
| Jun 30, 2018 | 242,000.00 |
| Jun 30, 2018 | 242,000.00 |
| Mar 31, 2018 | 129,000.00 |
| Mar 31, 2018 | 129,000.00 |
| Sep 30, 2017 | 1.77 Mn |
| Sep 30, 2017 | 1.77 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Mar 31, 2017 | 656,000.00 |
| Mar 31, 2017 | 656,000.00 |
| Dec 31, 2016 | 3.25 Mn |
| Dec 31, 2016 | 3.25 Mn |
| Sep 30, 2016 | -1.86 Mn |
| Sep 30, 2016 | -1.86 Mn |
| Jun 30, 2016 | 1.58 Mn |
| Jun 30, 2016 | 1.58 Mn |
| Mar 31, 2016 | 526,000.00 |
| Mar 31, 2016 | 526,000.00 |
| Dec 31, 2015 | 401,000.00 |
| Dec 31, 2015 | 401,000.00 |
| Sep 30, 2015 | 190,000.00 |
| Sep 30, 2015 | 190,000.00 |
| Jun 30, 2015 | 727,000.00 |
| Jun 30, 2015 | 727,000.00 |
| Mar 31, 2015 | 113,000.00 |
| Mar 31, 2015 | 113,000.00 |